Magnetic resonance imaging of multiple sclerosis lesions;Visualisation I.R.M. des lesions de S.E.P.

Revue Neurologique

Volumn 154, Issue 8-9, 1998, Pages 607-617

  Berry, I ^a,b   Ranjeva, J P ^b   Manelfe, C ^b   Clanet, M ^b  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISABILITY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIA; DATA INTERPRETATION, STATISTICAL; DIFFUSION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0031697020     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (60)

1. ACKERMAN J.J.H., GROVE T.H., WONG G.G., GADIAN D.G., RADDA G.K. (1980). Mapping of metabolites in whole animals by 31P N.M.R. using surface coils. Nature, 283: 167-170.
2. ARNOLD D.L, MATTHEWS P.M., FRANCIS G., ANTEL J. (1990) Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of M.S.: assessment of the load of the disease. Magn. Reson. Med, 14: 154-159.
3. BAKAY L., KURLAND R.J., PAPRISH R.G., LEE J.C., PENG R.J., BARKOWSKI H.M. (1975). Nuclear magnetic resonance studies in normal and edematous brain tissue. Exp Brain Res, 23: 241-248.
4. BARANY M., LANGER B.G., GLICK R.P., VENKATSUBRAMANIAN P.M., WLBUJR A.C., SPIGOS D.G. (1988). In vivo 1H spectroscopy in humans at 1.5 T. Radiology, 167: 839-844.
5. BARKHOF F., FILIPPI M., MILLER D.H., SCHELTENS P., CAMPI A., POLMAN C.H., COMI G., ADER H.J., LOSSEFF N., VALK J. (1997a). Comparison of M.R.I. criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain, 120: 2059-2069.
6. BARKHOF F., FILIPPI M., MILLER D.H., TOFTS P., KAPPOS L., THOMPSON A.J. (1997b). Strategies for optimizing M.R.I. techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J Neurol, 244: 76-84.
7. BASTIANELLO S., BOZZAO A., PAOULLO A., GIUGNI E., GASPERINI C., KOUDRIAVTSEVA T., MILLEFIORINI E., HORSFIELD M.A., COLONNESE C., TONI D., FIORELLI M., POZZILLI C., BOZZAO L. (1997). Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for M.R. quantification of multiple sclerosis lesions. Am J Neuroradiol, 18: 580-582.
8. BERRY I., BRANT-ZAWADZKI M., BRASCH R., OSAKI L., MUROVICK J., NEWTON T.H. (1986). Gd-D.T.P.A. in clinical M.R. of the brain: 2. extraaxial lesions and normal structures. AJNR, 7: 789-793.
9. BERRY I., BARKER G., BARKHOF F., CAMPI A., DOUSSET V., FRANCONO J.M., TOFTS P. (1996). A multicentre measurement of magnetization transfer ratio in normal white matter. Proc. Int. Soc. Magn. Reson. Med, 1: 536.
10. BOTTOWLEY P.A., HART H.R., EDELSTEIN W.A., SCHENCK J.F., SMITH L.S., LEUE W.M., MUELLER O.M., REDINGTON R.W. (1983). N.M.R. imaging/spectroscopy system to study both anatomy and metabolism. Lancet, 1: 273-274.
11. BRANT-AWADZKI M., DAVIS P.L., CROOKS L.E., MILLS C.M., NORMAN D., NEWTON T.H., SHELDON P., KAUFMAN L. (1983). N.M.R. demonstration of cerebral abnormalities: comparison with CT. AJNR, 4: 117-124.
12. BRANT-ZAWADZKI M., NORMAN D., NEWTON T.H., KELLY W.M., KJOS B., MILLS C.M., DILLON W., SOBEL D., CROOKS L.E. (1984). Magnetic resonance of the brain: the optimal screening technique. Radiology, 152: 71-77.
13. BRANT-ZAWADZKI M., BERRY I., OSAKI L., BRASCH R.C., MUROVICK J., NORMAN D. (1986). Gd-D.T.P.A. in clinical M.R. imaging of the brain: 1. intraaxial lesions. AJNR, 7: 781-788.
14. BRUCK W., BITSCH A., KOLENDA H., BRUCK Y., STIEFEL M., LASSMANN H. (1997). Inflammatory central nervous system demyelination: correlaton of magnetic resonance imaging findings with lesion pathology. Ann Neurol, 42: 783-793.
15. BYDDER G.M., STEINER R.E., YOUNG I.R., HALL A.S., THOMAS D.J., MARSHALL J., PALLIS C.A., LEGG N.J. (1982). Clinical N.M.R. imaging of the brain: 140 cases. AJNR, 3: 459-480.
16. CLANET M., BERRY I., BOULANOUAR K. (1997). Functional imaging in M.S. Int. M.S. J. 4: 26-32.
17. CROOKS L., HOENNINGER J., ARAKAWA M., KAUFMAN L., MCREE R., WATTS J., SINGEN J.H. (1980). Tomography of hydrogen with nuclear magnetic resonance. Radiology, 136: 701-706.
18. DAVIE C.A., BARKER G.J., THOMPSON A.J.,TOFTS P.S., MC DONALD W.I., MILLER D.H. (1997). 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry, 63: 736-742.
19. FAZEKAS F., OFFENBACHER H., FUCHS S., SCHMIDT R., NIEDERKORN K., HORNE S. (1988). Criteria for an increased specificity of M.R.I, interpretation in elderly subjects with suspected M.S. Neurology 38: 1822-1825.
20. FILIPPI M., CAMPI A., DOUSSET V., BARATTI C., MARTINELLI V., CANAL N., SCOTTI G., COMI G.A. (1995). A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology, 45: 478-482.
21. FILIPPI M., YOUSRY T.A., ALKADHI H., STEHLING M., HORSFIELD M.A., VOLTZ R. (1997a). Spinal cord M.R.I, in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast F.L.A.I.R. J Neurol, 244: 76-84.
22. FLIPPI M., CAMPI A, MARTINO G., COLOMBO B., COMI G. (1997b). Magnetization transfer study of white matter in siblings of multiple sclerosis patients. J Neurol Sci, 147: 151-153.
23. FILIPPI M., ROCCA M.A., MARTINO G., HORSFIELD M.A., COMI G. (1998). Magnetization transfer changes in the normal appearing white matter precede the appearance ofenhancing lesions in patients with multiple sclerosis. Ann Neurol, 43: 809-814.
24. Fu L., MATTHEWS P.M., DE STEFANO N., WORSLEY K.J., NARAYANAN S., FRANCIS G.S., ANTEL J.P., WOLFSON C., ARNOLD D.L. (1998). Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain, 121: 103-113.
25. GADIAN D.G., RADDA G.K., RICHARDS R.E., SCELEY P.J. (1979) 31P N.M.R. in living tissues; the road from a promising to an important tool in biology. In: Biological applications of Magnetic Resonance. Ed. by R.G.Shulman, Academic Press. New York, pp. 463-535.
26. GASS A., BARKER G.J., KIDD D., THORPE J.W., MACMANUS D., BRENNAN A., TOFTS P.S., THOMPSON A.J., MC DONAL W.I., MILLER D.H. (1994). Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Annals of neurol. 36: 62-67.
27. HOHOL M.J., GUTTMANN C.R.G., ORAY J., MACKIN G.A., KIKINIS R., KHOURY S.J., JOLESZ F.A., WEINER H.L. (1997). Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol, 54: 1018-1024.
28. HORSFIELD M.A., LAI M., WEBB S.L., BARKER J.F., TOFTS P.S., TURNER R. (1996). Apparent diffusion coefficient in benign and secondary progressive M.S. by nuclear MR. Magn. Reson. Med. 36: 393-400.
29. LE BIHAN D., BRETON E., LALLEMAND D., GRENIER P., CABANIS E., LAVAL-JEANTET M. (1986). MR Imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology, 161: 401-407.
30. LENKINSKI R.E., HOLLAND G.A., ALLMAN T., VOGELE K., KRESSEL H.Y., GROSSMAN R.I., CHARLES C.H., ENGESETH H.R., FLAMIG D., MAC FALL J.R. (1988). Integrated M.R. imaging and spectroscopy with chemical shift imaging of P-31 at 1.5 T: initial clinical experience. Radiology, 169: 201-206.
31. LOSSEFF N.A., WEBB S.L., O'RIORDAN J.L., PAGE R., WANG W.L., BARKER G.J., TOFTS P.S., MC DONALD W.I., MILLER D.H., THOMPSON A.J. (1996a). Spinal cord atrophy and disability in M.S.: a new reproducible and sensitive M.R.I. method with potential to monotor disease progression. Brain, 119: 701-708.
32. LOSSEFF N.A., WANG L., LAI H.M., Yoo D.S., GAWNE-CAIN M.L., MC DONALD W.I., MILLER D.H., THOMPSON A.J.(1996b). Progressive cerebral atrophy in M.S. A serial M.R.I. study. Brain, 119: 2009-2019.
33. MILLER D.H., ALBERT P.S., BARKHOF F., FRANCIS G., FRANK J.A., HODGKINSON S. et al., (1996). Guidelines for the use of M.R. techniques in monitoring the treatment of M.S. Ann Neurol, 39: 6-16.
34. MILLER D.H., GROSSMAN R.I., REINGOLD S.C., MC FARLAND H.F. (1998). The role of M.R. techniques in understanding and managing multiple sclerosis. Brain, 121: 3-24.
35. MORRISSEY S.P., STODAL H., ZETTL U., SIMONIS C., JUNG S., KIEFER R., LASSMANN H., HARTUNG H.P., HAASE A., TOYKA K.V. (1996). In vivo M.R.I. and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis.Quantification of inflammation and œdema. Brain. 119: 239-248.
36. NARAYANAN S., Fu L., PIORO E., DE STEFANO N., COLLINS D.L., FRANCIS G.S., ANTEL J.P., MATTHEWS P.M., ARNOLD D.L. (1997). Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol, 41: 385-391.
37. NARAYANA P.A., DOYLE T.J., LAI D., WOLINSKY J.S. (1998). Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol, 43: 56-71.
38. OGAWA S., LEE T.-M., NAYAK A.S., GLYNN P. (1990) Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med, 14: 68-78.
39. PATY D.W., OGER J.J.F., KASTRUKOFF F.F., HASHIMOTO S.A., HOOGE J.P., EISFN A.A. (1988). M.R.I. in the diagnosis of M.S.: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and C.T. Neurology, 38: 180-185.
40. Proceedings of the M.S. Forum Modern Management Workshop (1997). Imaging in Multiple Sclerosis. Worthing: PPS Europe Ltd.
41. RANJEVA J.P., FRANCONI J.M., MANELFE C., BERRY I. (1997). Magnetization transfer with echo planar imaging. MAGMA, 5: 259-265.
42. ROVARIS M., FILIPPI M., CALORI G., RODEGHER M., CAMPI A., COLOMBO B., COM G. (1997). Magnetisation transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis. Neuroradiology, 39: 441-447.
43. RUDICK R., ANTEL J., CONFAVREUX C., CUTTER G., ELUSON G., FISCHER J. et al., (1996). Clinical outcome assessment in M.S. (review). Ann Neurol, 40: 469-479.
44. SILVER N.C., GOOD C.D., BARKER G.J., MACMANUS O.G., THOMPSON A.J., MOSELEY I.F., MC DONALD W.I., MILLER D.H. (1997a). Sensitivity of contrast enhanced M.R.I. in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain, 120: 1749-1761.
45. SILVER N.C., BARKER R.A., MAC MANUS D.G., BARKER G.J., THOM M., THOMAS D.G.T., MC DONALD W.I., MILLER D.H. (1997b). Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion. J Neurol. 244: 204-207.
46. SIMON J.H., JACOBS L.D., CAMPION M., WENDE K., SIMONIAN N., COOKFAIR D.L., RUDICK R.A., HERNDON R.M., RICHERT J.R., SALAZAR A.M., ALAM J.J., FICHER J.S., GOODKIN DE GRANGER C.V., LAJAUNIE M., MARTENS-DAVIDSON A.L., MEYER M., SHEEDER J., CHOI K., SCHERZINGER A.L., BARTOSZAK D.M., BOURDETTE D.N., BRAJMAN J., BROWNSCHEIDLE C.M., WHITHAM R.H., et al., (1998). Magnetic resonance studies of intramuscular Interferon beta-1 a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Ann Neurol, 43: 79-87.
47. STEVENSON V.L., GAWNE-CAIN M.L., BARKER G.J., THOMPSON A.J., MILLER D.H. (1997). Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast flair and fast spin echo. J Neurol, 244: 119-124.
48. STONE L.A., FRANK J.A., ALBERT P.S., BASH C., SMITH M.E., MALONI H., MC FARLAND H.F. (1995). The effect of Interferon beta on the brain barrier disruption demonstrated by contrast enhanced M.R.I. in relapsing remitting M.S. Ann Neurol, 66: 147-151.
49. STORCH M., LASSMANN H. (1997). Pathology and pathogenesis of demyelinating diseases. Curr. Op. Neurol 10: 186-192.
50. The I.F.N.B. Multiple Sclerosis Study Group: University of British Columbia M.S./M.R.I. analysis group (1995). Interferon beta 1b in the treatment of M.S. Final outcome of the randomized controlled trial. Neurology. 45: 1277-1285.
51. THORPE J.W., KIDD D., MOSELEY I.F., THOMPSON A.J., MAC MANUS D.G., COMPSTON D.A. (1996). Spinal M.R.I. in patients with suspected M.S. and negative brain M.R.I. Brain, 119: 709-714.
52. TRAPP B.D., PETERSON D.H., RANSOHOF R.M., RUDICK R., MORK S., BO L. (1998). Axonal transection in the lesions of M.S. N Engl J Med, 338: 278-285.
53. TUBRIDY N., COLES A.J., MOLYNEUX P., COMPSTON D.A.S., BARKHOF F., THOMPSON A.J., MC DONALD W.I., MILLER D.H. (1998). Secondary progressive multiple sclerosis: the relationship between short-term M.R.I. activity and clinical features. Brain, 121: 225-231.
54. UHLENBROCK D., SEHLEN S. (1989). The value of T1-weighted images in the differentaition between M.S., white matter lesions, and subcortical arteriosclerotic encephalopathy. Neuroradiology, 13: 227-231.
55. VAN BUCHEM M.A., MC GOWAN G.C., KOLSON D.L., GROSSMAN R.I. (1996) Quantitative volumetric magnetization transfer analysis in M.S. Estimation of macroscopic and microscopic disease burden. Mag Reson Med, 36: 632-636.
56. VAN WALDERVEEN M.A.A., BARKHOF F., HOMMES O.R., POLMAN C.H., TOBI H., FREQUIN S.T. (1995). Correlating M.R.I. and clinical disease activity in M.S.: relevance of hypointense lesions on short T.R./short T.E. (T1-weighted)spin echo images. Neurology, 45: 1684-1690.
57. VAN WALDERVEEN M.A.A., SCHELTSTEN P., VAN WAESBERGHE J.H.T.M., RAVID R., POLMAN C.H., VALK J. (1997). Hypointense lesions on T1-weighted SE M.R. images correlate with axonal loss in M.S. J. Neurol, 244. S84. P410.
58. WANG L., LAI H.M., THOMSON A.J., MILLER D.H. (1996) Accumulation of hypointense lesions ("black holes") on T1 spin-echo M.R.I correlates with disease progression in multiple sclerosis. Neurology. 47: 1469-1476.
59. WARACH S., DASHE J.F., EDELMAN R.R. (1996). Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cerebr Bl Flow Metab, 16: 53-59.
60. YOUSRY T.A., FILIPPI M., BECKER C., HORSFIELD M.A., VOLTZ R. (1997). Comparison of M.R. pulse sequences in the detection of multiple sclerosis lesions. J Neurol, 244: 119-124.